Department of Ophthalmology, Tel Aviv Medical Center, Sidney A Fox Chair in Ophthalmology, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ophthalmic Res. 2012;48 Suppl 1:11-5. doi: 10.1159/000339842. Epub 2012 Aug 21.
Early treatment for choroidal neovascularization (CNV) is an important part of preserving visual function for patients with age-related macular degeneration. Preferential hyperacuity perimetry (PHP) provides high accuracy, sensitivity and specificity for detecting changes in lesions in diagnostic and treatment stages. The ForeseeHome is a PHP device designed for home use by patients. Regular use alerts retina specialists and patients of detected changes and allows patients to come in for visits when CNV begins or recurs. To maximize the benefit of recent breakthroughs in CNV treatment, patients should be better monitored with the ForeseeHome to detect new CNV while their vision is still good, and to promptly manage recurrence after treatment.
早期治疗脉络膜新生血管(CNV)是保存老年黄斑变性患者视力功能的重要环节。优先超敏视野计(PHP)在诊断和治疗阶段检测病变变化具有高精度、高灵敏度和高特异性。ForeseeHome 是一种专为患者在家中使用而设计的 PHP 设备。定期使用可以提醒视网膜专家和患者注意到检测到的变化,并在 CNV 开始或复发时允许患者进行就诊。为了最大限度地受益于 CNV 治疗的最新突破,应使用 ForeseeHome 对患者进行更好的监测,以在视力良好时检测到新的 CNV,并在治疗后及时处理复发。